Takis Biotech
  • Home
  • About us
  • Leadership
  • Research
    • Papers
    • Progetti
  • News
    • Archive News
    • Archive Newsletter

Contact

Takis biotech

Takis services

Takis products

Takis Biotech
  • Home
  • About us
  • Leadership
  • Research
    • Papers
    • Progetti
  • News
    • Archive News
    • Archive Newsletter

Takis biotech

Takis services

Takis products

Assobiotec

Merry Christmas from Takis Biotech!Sent on 23 December 2020
Takis Biotech starting preclinical experimentation with COVID-19 vaccineSent on 17 March 2020
Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNAT Vaccine Candidates Designed Sent on 02 March 2020
Coronavirus vaccine: Takis Biotech on the frontline Sent on 17 February 2020
Takis/Evvivax announce the research activity for the development of a Vaccine against Wuhan Coronavirus 2019-nCoVSent on 27 January 2020
Takis second Biotech in Europe at EIT Health Catapult Final!Sent on 07 December 2019
European EIT Health Biotech Final: Forza Takis and Forza Italia!Sent on 30 November 2019
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor ReductionSent on 25 September 2019
Takis Innovation and Health Technologies awarded in Lazio RegionSent on 16 July 2019
Takis Antibodies TraZimAb and Rever3mAb moving forward!Sent on 10 July 2019
Takis Biotech Research moving forward!Sent on 19 June 2019
TAKIS announces a collaboration partnership with TRIANNI for Human Therapeutic Antibody generationSent on 10 April 2019
LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccinesSent on 29 September 2018
Display #
Results 1 - 13 out of 13
  • Terms of use
  • Privacy
  • Ethical code
  • This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Webmail